Close Menu

NEW YORK (360Dx) – Mologic said today that it has signed European distribution agreements for its Periplex point-of-care test for detection of infections in patients undergoing peritoneal dialysis.

The Periplex test detects two biomarkers of infection — interleukin 6 and matrix metalloproteinase-8 — in peritoneal dialysis waste fluid using a lateral flow immunoassay system, and provides results within 10 minutes. It received CE marking about a year ago.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.